| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 03/03/2025 | 22:17 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | AMEX:SENS | Senseonics Holdings Inc |
| 03/03/2025 | 22:05 | GlobeNewswire Inc. | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results | AMEX:SENS | Senseonics Holdings Inc |
| 26/02/2025 | 13:30 | GlobeNewswire Inc. | Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care | AMEX:SENS | Senseonics Holdings Inc |
| 13/02/2025 | 22:05 | GlobeNewswire Inc. | Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference | AMEX:SENS | Senseonics Holdings Inc |
| 12/02/2025 | 22:07 | GlobeNewswire Inc. | Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for March 3, 2025 at 4:30 P.M. Eastern Time | AMEX:SENS | Senseonics Holdings Inc |
| 06/02/2025 | 22:05 | GlobeNewswire Inc. | Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor | AMEX:SENS | Senseonics Holdings Inc |
| 17/01/2025 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:SENS | Senseonics Holdings Inc |
| 09/01/2025 | 00:12 | GlobeNewswire Inc. | Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting | AMEX:SENS | Senseonics Holdings Inc |
| 04/01/2025 | 00:49 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 09/12/2024 | 22:29 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | AMEX:SENS | Senseonics Holdings Inc |
| 09/12/2024 | 14:00 | GlobeNewswire Inc. | Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch | AMEX:SENS | Senseonics Holdings Inc |
| 09/12/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | AMEX:SENS | Senseonics Holdings Inc |
| 29/11/2024 | 13:00 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | AMEX:SENS | Senseonics Holdings Inc |
| 27/11/2024 | 22:06 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of 1933 | AMEX:SENS | Senseonics Holdings Inc |
| 19/11/2024 | 23:15 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | AMEX:SENS | Senseonics Holdings Inc |
| 12/11/2024 | 14:00 | GlobeNewswire Inc. | Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences | AMEX:SENS | Senseonics Holdings Inc |
| 08/11/2024 | 22:13 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities | AMEX:SENS | Senseonics Holdings Inc |
| 07/11/2024 | 22:26 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | AMEX:SENS | Senseonics Holdings Inc |
| 07/11/2024 | 22:05 | GlobeNewswire Inc. | Senseonics Holdings, Inc. Reports Third Quarter 2024 Financial Results | AMEX:SENS | Senseonics Holdings Inc |
| 28/10/2024 | 12:30 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | AMEX:SENS | Senseonics Holdings Inc |
| 25/10/2024 | 14:00 | GlobeNewswire Inc. | Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering | AMEX:SENS | Senseonics Holdings Inc |
| 24/10/2024 | 14:00 | GlobeNewswire Inc. | Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time | AMEX:SENS | Senseonics Holdings Inc |
| 16/10/2024 | 22:30 | GlobeNewswire Inc. | Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System | AMEX:SENS | Senseonics Holdings Inc |
| 10/10/2024 | 22:10 | PR Newswire (US) | Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor | AMEX:SENS | Senseonics Holdings Inc |
| 10/10/2024 | 22:05 | GlobeNewswire Inc. | Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor | AMEX:SENS | Senseonics Holdings Inc |
| 17/09/2024 | 17:50 | AllPennyStocks.com | FDA Clearance Announcement Sends Small Cap Soaring | AMEX:SENS | Senseonics Holdings Inc |
| 17/09/2024 | 13:00 | GlobeNewswire Inc. | Eversense 365 Receives FDA Clearance: The World’s First One Year CGM | AMEX:SENS | Senseonics Holdings Inc |
| 06/09/2024 | 22:05 | GlobeNewswire Inc. | Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference | AMEX:SENS | Senseonics Holdings Inc |
| 08/08/2024 | 22:05 | Business Wire | Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results | AMEX:SENS | Senseonics Holdings Inc |
| 25/07/2024 | 22:05 | Business Wire | Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time | AMEX:SENS | Senseonics Holdings Inc |
